InMed Pharmaceuticals Inc. Quarterly Costs and Expenses in USD from Q3 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
InMed Pharmaceuticals Inc. quarterly Costs and Expenses history and growth rate from Q3 2021 to Q1 2023.
  • InMed Pharmaceuticals Inc. Costs and Expenses for the quarter ending March 31, 2023 was -$2.34M, a 37.1% increase year-over-year.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$2.34M +$1.38M +37.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$2.37M +$2.06M +46.5% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-17
Q3 2022 $3.83M +$859K +28.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q1 2022 -$3.72M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$4.42M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-17
Q3 2021 $2.97M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.